Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Heliox inspirate
United Therapeutics Europe Ltd
Work of Breathing
1 trial -
Hemlibra 150 mg/mL solution for injection
Hoffmann-La Roche
Severe or Moderate Hemophilia A
1 trial -
Hemlibra 150 mg/mL solution for injection, Hemlibra 30 mg/mL solution for injection, Hemlibra 30 mg/mL solution for injection, Hemlibra 150 mg/mL solution for injection, Hemlibra 150 mg/mL solution for injection, Hemlibra 150 mg/mL solution for injection
Disc Medicine
Congenital Haemophilia A
1 trial -
Hepatitis B vaccine
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Hepatitis B Vaccination, HIV
1 trial -
Hiconcil 500 mg trde kapsule, Enterol 250 mg, gélules, Matched Placebo will consist in caspules similar to the 250 mg capsules of the Saccharomyces boulardii CNCM-I-745 but with no active ingredient
Biocodex
Patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis))
1 trial -
Hidrathea 9 mg/ml colirio en solución, Plasma rich in growth factors, Artific 3,20 mg/ml colirio en solución
Wuhan Createrna Science and Technology Co., Ltd
Dry Eye Disease
1 trial -
Honghe Fujie lotion
The First People's Hospital of Lianyungang
Bacterial Vaginitis
1 trial -
Humira 40 mg solution for injection in pre-filled pen, ORENCIA 125 mg solution for injection in pre-filled syringe, Enbrel 50 mg solution for injection in pre-filled syringe, Reumaflex 50 mg/ml soluzione iniettabile, siringa preriempita, ORENCIA 250 mg powder for concentrate for solution for infusion, Cosentyx 150 mg solution for injection in pre-filled syringe, Enbrel 25 mg solution for injection in pre-filled syringe, Simponi 45 mg/0.45 mL solution for injection in pre-filled pen., Jylamvo 2 mg/ml oral so
Istituto Gentili S.r.l.
Juvenile idiopathic arthritis
1 trial -
Hydrocortisone Acetate 1% Ointment
BRIGHT MINDS BIOSCIENCES INC.
Postoperative Sore Throat, Cough, Hoarseness
1 trial -
Hydroxychloroquine Sulfate 200 Mg Tablet
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
Hyperbaric bupivacaine+Sufentanil
Lxo Ireland Designated Activity Company
Anesthesia; Functional
1 trial -
ICD Ablation plus VT-ablation
Rhythm Pharmaceuticals Netherlands B.V.
Tachycardia, Ventricular
1 trial -
IIV4 and PPV23
BRIGHT MINDS BIOSCIENCES INC.
Influenza, Human
1 trial -
IMFINZI 50 mg/mL concentrate for solution for infusion., Lynparza 100 mg film-coated tablets, Lynparza 150 mg film-coated tablets
AstraZeneca
Advanced or recurrent endometrial cancer
1 trial -
IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM., Rixathon 500 mg concentrate for solution for infusion, Bortezomib Hikma 3,5 mg Pulver zur Herstellung einer Injektionslösung, Rixathon 100 mg concentrate for solution for infusion, MTX HEXAL 2,5 mg Tabletten, -, Methotrexat-GRY® 50 mg/2 ml Injektionslösung, ASFOTASE ALFA
Alexion Europe SAS
HYPOPHOSPHATASIA
1 trial -
IODEX® balm
GlaxoSmithKline
Pain
1 trial -
IPTACOPAN HYDROCHLORIDE, IPTACOPAN
Novartis Pharmaceuticals
C3 Glomerulopathy or idiopathic immune-complex membranoproliferative glomerulonephritis
1 trial -
IRON OXIDE (E172)
Disc Medicine
Glioblastoma
1 trial -
IV morphine sulfate
Pacira Ireland Limited
Bowel Obstruction
2 trials -
IV morphine sulfate or Sponsor-approved equivalent
Pacira Ireland Limited
Bowel Obstruction
1 trial -
IV morphine sulfate or Sponsor-approved equivalent
Pacira Ireland Limited
Retraction of Colostomy
1 trial -
IXCHIQ
Ars Pharmaceuticals Irl Limited
Chikungunya Virus Infection
1 trial -
Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Ductus Arteriosus, Patent
1 trial -
Icodextrin Peritoneal Dialysis Solution
The First People's Hospital of Lianyungang
Peritoneal Dialysis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources